Blue Crest Capital Management LTD G1 Therapeutics, Inc. Transaction History

Blue Crest Capital Management LTD

  • $3.2 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019
SELL
$16.51 - $51.33 $82,649 - $256,957
-5,006 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$43.15 - $67.97 $216,008 - $340,257
5,006 New
5,006 $262,000
Q2 2018

Aug 14, 2018
SELL
$35.06 - $51.17 $211,832 - $309,169
-6,042 Closed
0 $0
Q1 2018

May 15, 2018
BUY
$19.05 - $41.76 $115,100 - $252,313
6,042 New
6,042 $224,000

Others Institutions Holding GTHX

# of Institutions
6
Shares Held
3.55M
Call Options Held
11.7K
Put Options Held
0
View Full List

About G1 Therapeutics, Inc.

GTHX Quotes by TradingView
  • Ticker GTHX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,746,800
  • Market Cap $306M
  • Description
  • G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...
More about GTHX
Track This Portfolio

Track Blue Crest Capital Management LTD Portfolio

Follow Blue Crest Capital Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blue Crest Capital Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Blue Crest Capital Management LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email